MDisrupt Webinars

Building digital health products that scale—why chief medical and scientific officers are the key to widespread adoption

Date: Tuesday, August 24, 2021
Time: 11:00AM – 12:00PM PST

Chief Medical Officers and Chief Scientific Officers are critical first hires for a digital health company. From accelerating your product’s path to market to ensuring your claims are bound by science and balancing consumer needs with medical integrity, CMOs and CSOs can be a founding team’s lifeboat.

In this webinar, we’ll cover:

• A day in the life of a CMO or CSO in a digital health company
• How CMOs and CSOs with varying backgrounds can play important roles in your business
• The clash between the commercial mindset and medical responsibility
• What happens when you don’t have a CMO or CSO from the start

Panelists:

The roles physicians can play in digital health

Date: June 15, 2021
Time: 11:00AM – 12:00PM PST

Beyond the clinic, physicians can play key roles in digital health companies, from helping them build better products faster to being a founder and even an investor. As a clinician, you can have a voice in how digital health products are designed, marketed, and distributed to your peers.

In this webinar, we will cover:

• Roles physicians can play in digital health companies
• How to translate a physician’s clinical experience into industry settings
• Where physicians can have a voice early on within companies
• How to represent the voice of the clinician in product design and evidence generation

Panelists:

How will value-based care drive digital health companies to show outcomes and improve evidence generation?

Date: April 13, 2021
Time: 11:00AM – 12:00PM PST

By 2026, health systems will need to show a shift from a fee-for-service model to a value-based care model. This will require health systems, payers, and digital health companies to work together to determine what evidence is needed to demonstrate outcomes. Where do health systems and payers even start in tackling this challenge? It’s all in the numbers . . .

In this webinar, we will cover:

• What does value-based care mean and what challenges does it pose to our current healthcare ecosystem?
• What evidence will digital health companies need to generate to convince payers, providers, and health systems in a value-based care setting?
• What types of outcomes do health systems and payers care about measuring?
• What types of studies should digital health companies be conducting?
• What do digital health companies need to do differently to increase their chances of adoption in value-based care settings?

Panelists:

How will regulation of digital health products be impacted with the new administration?

Date: March 9, 2021
Time: 11:00AM – 12:00PM PST

With the transition to the Biden-Harris Administration, appointing new leadership within the healthcare focused agencies, and the swearing in of the new Congress, the precision medicine industry can expect new attention to critical policy issues including regulation of diagnostic testing, digital health platforms, and at home testing. Is your regulatory team prepared for these changes?

In this webinar, we will cover:

• What are the priorities of the incoming administration and new Congress?
• How will these priorities shift the way the FDA is thinking about regulating laboratory developed tests and digital health software?
• How should regulatory teams in digital health companies start to prepare for these shifts?
• How will your legal team be thinking about recently implemented regulations during and after the transition?

Panelists:

Reimagining Population Health Management

Can Genomics Evolve our Sick Care System into a True Healthcare System

Date: December 15, 2020
Time: 11:30 am – 12:30 pm PST

Imagine if our healthcare system could actually prevent us from becoming patients in the first place.

In today’s healthcare, we use only 10% of the data that predicts health outcomes. Genetic information has the potential to radically improve our predictive power and to help risk-stratify the patients at highest and lowest risk of common chronic diseases such as diabetes, cardiovascular disease, and hypertension.

This webinar will explore how using genetics as a routine part of our healthcare can help us improve population health management—by identifying the highest-risk patients and proactively delivering personalized, preventive interventions to the right patients at the right time.

Key themes

• The channels, tools, and delivery methods that could be used for population health management;
• How genomics can be paid for when applied as a population health management tool in the transition to value-based care; and
• How digital health companies should think about building solutions for population health management.

Panelists:

Social Determinants of Health in the Virtual Care Setting

Date: November 17, 2020
Time: 11:00 am – 12:00 pm PST

In the time of COVID-19, digital health and telehealth capacities are ramping up. These technologies often point to solutions for specific chronic conditions. In this webinar, learn from experts about:

• How chronic conditions are often underpinned by behavioral complexities such as smoking, diet, alcohol use, physical activity, etc.
• How digital and healthtech companies can integrate behavioral, social, and clinical care data into product design to create context-aware, intelligent solutions

Panelists: